Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Authors
Fachal, LAschard, H
Beesley, J
Barnes, DR
Allen, J
Kar, S
Pooley, KA
Dennis, J
Michailidou, K
Turman, C
Soucy, P
Lemacon, A
Lush, M
Tyrer, JP
Ghoussaini, M
Marjaneh, MM
Jiang, X
Agata, S
Aittomaki, K
Alonso, MR
Andrulis, IL
Anton-Culver, H
Antonenkova, NN
Arason, A
Arndt, V
Aronson, KJ
Arun, BK
Auber, B
Auer, PL
Azzollini, J
Balmana, J
Barkardottir, RB
Barrowdale, D
Beeghly-Fadiel, A
Benitez, J
Bermisheva, M
Bialkowska, K
Blanco, AM
Blomqvist, C
Blot, W
Bogdanova, NV
Bojesen, SE
Bolla, MK
Bonanni, B
Borg, A
Bosse, K
Brauch, H
Brenner, H
Briceno, I
Brock, IW
Brooks-Wilson, A
Bruning, T
Burwinkel, B
Buys, SS
Cai, Q
Caldes, T
Caligo, MA
Camp, NJ
Campbell, I
Canzian, F
Carroll, JS
Carter, BD
Castelao, JE
Chiquette, J
Christiansen, H
Chung, WK
Claes, KBM
Clarke, CL
Collee, JM
Cornelissen, S
Couch, FJ
Cox, A
Cross, SS
Cybulski, C
Czene, K
Daly, MB
de la Hoya, M
Devilee, P
Diez, O
Ding, YC
Dite, GS
Domchek, SM
Dork, T
Dos-Santos-Silva, I
Droit, A
Dubois, S
Dumont, M
Duran, M
Durcan, L
Dwek, M
Eccles, DM
Engel, C
Eriksson, M
Evans, DG
Fasching, PA
Fletcher, O
Floris, G
Flyger, H
Foretova, L
Foulkes, WD
Friedman, E
Fritschi, L
Frost, D
Gabrielson, M
Gago-Dominguez, M
Gambino, G
Ganz, PA
Gapstur, SM
Garber, J
Garcia-Saenz, JA
Gaudet, MM
Georgoulias, V
Giles, GG
Glendon, G
Godwin, AK
Goldberg, MS
Goldgar, DE
Gonzalez-Neira, A
Tibiletti, MG
Greene, MH
Grip, M
Gronwald, J
Grundy, A
Guenel, P
Hahnen, E
Haiman, CA
Hakansson, N
Hall, P
Hamann, U
Harrington, PA
Hartikainen, JM
Hartman, M
He, W
Healey, CS
Heemskerk-Gerritsen, BAM
Heyworth, J
Hillemanns, P
Hogervorst, FBL
Hollestelle, A
Hooning, MJ
Hopper, JL
Howell, Anthony
Huang, G
Hulick, PJ
Imyanitov, EN
Isaacs, C
Iwasaki, M
Jager, A
Jakimovska, M
Jakubowska, A
James, PA
Janavicius, R
Jankowitz, RC
John, EM
Johnson, N
Jones, ME
Jukkola-Vuorinen, A
Jung, A
Kaaks, R
Kang, D
Kapoor, PM
Karlan, BY
Keeman, R
Kerin, MJ
Khusnutdinova, E
Kiiski, JI
Kirk, J
Kitahara, CM
Ko, YD
Konstantopoulou, I
Kosma, VM
Koutros, S
Kubelka-Sabit, K
Kwong, A
Kyriacou, K
Laitman, Y
Lambrechts, D
Lee, E
Leslie, G
Lester, J
Lesueur, F
Lindblom, A
Lo, WY
Long, J
Lophatananon, A
Loud, JT
Lubinski, J
MacInnis, RJ
Maishman, T
Makalic, E
Mannermaa, A
Manoochehri, M
Manoukian, S
Margolin, S
Martinez, ME
Matsuo, K
Maurer, T
Mavroudis, D
Mayes, R
McGuffog, L
McLean, C
Mebirouk, N
Meindl, A
Miller, A
Miller, N
Montagna, M
Moreno, F
Muir, K
Mulligan, AM
Munoz-Garzon, VM
Muranen, TA
Narod, SA
Nassir, R
Nathanson, KL
Neuhausen, SL
Nevanlinna, H
Neven, P
Nielsen, FC
Nikitina-Zake, L
Norman, A
Offit, K
Olah, E
Olopade, OI
Olsson, H
Orr, N
Osorio, A
Pankratz, VS
Papp, J
Park, SK
Park-Simon, TW
Parsons, MT
Paul, J
Pedersen, IS
Peissel, B
Peshkin, B
Peterlongo, P
Peto, J
Plaseska-Karanfilska, D
Prajzendanc, K
Prentice, R
Presneau, N
Prokofyeva, D
Pujana, MA
Pylkas, K
Radice, P
Ramus, SJ
Rantala, J
Rau-Murthy, R
Rennert, G
Risch, HA
Robson, M
Romero, A
Rossing, M
Saloustros, E
Sanchez-Herrero, E
Affiliation
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UKIssue Date
2020
Metadata
Show full item recordAbstract
Genome-wide association studies have identified breast cancer risk variants in over 150 genomic regions, but the mechanisms underlying risk remain largely unknown. These regions were explored by combining association analysis with in silico genomic feature annotations. We defined 205 independent risk-associated signals with the set of credible causal variants in each one. In parallel, we used a Bayesian approach (PAINTOR) that combines genetic association, linkage disequilibrium and enriched genomic features to determine variants with high posterior probabilities of being causal. Potentially causal variants were significantly over-represented in active gene regulatory regions and transcription factor binding sites. We applied our INQUSIT pipeline for prioritizing genes as targets of those potentially causal variants, using gene expression (expression quantitative trait loci), chromatin interaction and functional annotations. Known cancer drivers, transcription factors and genes in the developmental, apoptosis, immune system and DNA integrity checkpoint gene ontology pathways were over-represented among the highest-confidence target genes.Citation
Fachal L, Aschard H, Beesley J, Barnes DR, Allen J, Kar S, et al. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nat Genet. 2020;52(1):56-73.Journal
Nature GeneticsDOI
10.1038/s41588-019-0537-1PubMed ID
31911677Additional Links
https://dx.doi.org/10.1038/s41588-019-0537-1Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41588-019-0537-1
Scopus Count
Collections
Related articles
- Identification of candidate causal variants and target genes at 41 breast cancer risk loci through differential allelic expression analysis.
- Authors: Xavier JM, Magno R, Russell R, de Almeida BP, Jacinta-Fernandes A, Besouro-Duarte A, Dunning M, Samarajiwa S, O'Reilly M, Maia AM, Rocha CL, Rosli N, Ponder BAJ, Maia AT
- Issue date: 2024 Sep 28
- Identification of breast cancer associated variants that modulate transcription factor binding.
- Authors: Liu Y, Walavalkar NM, Dozmorov MG, Rich SS, Civelek M, Guertin MJ
- Issue date: 2017 Sep
- Leveraging allelic imbalance to refine fine-mapping for eQTL studies.
- Authors: Zou J, Hormozdiari F, Jew B, Castel SE, Lappalainen T, Ernst J, Sul JH, Eskin E
- Issue date: 2019 Dec
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
- Authors: Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, Freeman A, Hopper JL, Milne RL, Bolla MK, Wang Q, Dennis J, Agata S, Ahmed S, Aittomäki K, Andrulis IL, Anton-Culver H, Antonenkova NN, Arason A, Arndt V, Arun BK, Arver B, Bacot F, Barrowdale D, Baynes C, Beeghly-Fadiel A, Benitez J, Bermisheva M, Blomqvist C, Blot WJ, Bogdanova NV, Bojesen SE, Bonanni B, Borresen-Dale AL, Brand JS, Brauch H, Brennan P, Brenner H, Broeks A, Brüning T, Burwinkel B, Buys SS, Cai Q, Caldes T, Campbell I, Carpenter J, Chang-Claude J, Choi JY, Claes KB, Clarke C, Cox A, Cross SS, Czene K, Daly MB, de la Hoya M, De Leeneer K, Devilee P, Diez O, Domchek SM, Doody M, Dorfling CM, Dörk T, Dos-Santos-Silva I, Dumont M, Dwek M, Dworniczak B, Egan K, Eilber U, Einbeigi Z, Ejlertsen B, Ellis S, Frost D, Lalloo F, EMBRACE, Fasching PA, Figueroa J, Flyger H, Friedlander M, Friedman E, Gambino G, Gao YT, Garber J, García-Closas M, Gehrig A, Damiola F, Lesueur F, Mazoyer S, Stoppa-Lyonnet D, behalf of GEMO Study Collaborators, Giles GG, Godwin AK, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Haiman CA, Hallberg E, Hamann U, Hansen TV, Hart S, Hartikainen JM, Hartman M, Hassan N, Healey S, Hogervorst FB, Verhoef S, HEBON, Hendricks CB, Hillemanns P, Hollestelle A, Hulick PJ, Hunter DJ, Imyanitov EN, Isaacs C, Ito H, Jakubowska A, Janavicius R, Jaworska-Bieniek K, Jensen UB, John EM, Joly Beauparlant C, Jones M, Kabisch M, Kang D, Karlan BY, Kauppila S, Kerin MJ, Khan S, Khusnutdinova E, Knight JA, Konstantopoulou I, Kraft P, Kwong A, Laitman Y, Lambrechts D, Lazaro C, Le Marchand L, Lee CN, Lee MH, Lester J, Li J, Liljegren A, Lindblom A, Lophatananon A, Lubinski J, Mai PL, Mannermaa A, Manoukian S, Margolin S, Marme F, Matsuo K, McGuffog L, Meindl A, Menegaux F, Montagna M, Muir K, Mulligan AM, Nathanson KL, Neuhausen SL, Nevanlinna H, Newcomb PA, Nord S, Nussbaum RL, Offit K, Olah E, Olopade OI, Olswold C, Osorio A, Papi L, Park-Simon TW, Paulsson-Karlsson Y, Peeters S, Peissel B, Peterlongo P, Peto J, Pfeiler G, Phelan CM, Presneau N, Radice P, Rahman N, Ramus SJ, Rashid MU, Rennert G, Rhiem K, Rudolph A, Salani R, Sangrajrang S, Sawyer EJ, Schmidt MK, Schmutzler RK, Schoemaker MJ, Schürmann P, Seynaeve C, Shen CY, Shrubsole MJ, Shu XO, Sigurdson A, Singer CF, Slager S, Soucy P, Southey M, Steinemann D, Swerdlow A, Szabo CI, Tchatchou S, Teixeira MR, Teo SH, Terry MB, Tessier DC, Teulé A, Thomassen M, Tihomirova L, Tischkowitz M, Toland AE, Tung N, Turnbull C, van den Ouweland AM, van Rensburg EJ, Ven den Berg D, Vijai J, Wang-Gohrke S, Weitzel JN, Whittemore AS, Winqvist R, Wong TY, Wu AH, Yannoukakos D, Yu JC, Pharoah PD, Hall P, Chenevix-Trench G, KConFab, AOCS Investigators, Dunning AM, Simard J, Couch FJ, Antoniou AC, Easton DF, Zheng W
- Issue date: 2016 Jun 21
- Allele-Specific QTL Fine Mapping with PLASMA.
- Authors: Wang AT, Shetty A, O'Connor E, Bell C, Pomerantz MM, Freedman ML, Gusev A
- Issue date: 2020 Feb 6